TBG Diagnostics Ltd. engages in the research, development, and manufacture of biopharmaceuticals. It operates through the InVitro Diagnostics segment, which involves in the research of biological drugs and the retail and wholesale of veterinary drugs. The company was founded on September 26, 1989 and is headquartered in Melbourne, Australia.
Company profile
Ticker
TDLAF
Exchange
Website
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Progen Industries LTD, Progen Pharmaceuticals LTD
SEC CIK
Corporate docs
Latest filings (excl ownership)
15F-12G
Securities registration termination (foreign)
5 Aug 16
6-K
Current report (foreign)
5 Aug 16
6-K
Current report (foreign)
27 Jul 16
6-K
Current report (foreign)
25 Jul 16
6-K
Current report (foreign)
19 Jul 16
6-K
Current report (foreign)
15 Jul 16
6-K
Current report (foreign)
31 May 16
6-K
TBG Diagnostics Receives Funding from Chinese Municipal Technology Bureau for HLA Typing KitDevelopment
26 May 16
6-K
Company Update – Board and Management Structure
18 May 16
6-K
Current report (foreign)
16 May 16
Latest ownership filings
No filings